Lowering the systolic blood pressure target in hypertensive patients: current controversies and future outlook

References

• Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–223.
   PubMed Web of Science ®Google Scholar
• GBD 2013. Mortality and causes of death collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–171.
   PubMed Web of Science ®Google Scholar
• Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557–1562.
   PubMed Web of Science ®Google Scholar
• McMurray JJ, Carson PE, Komajda M, et al. Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. Eur J Heart Fail. 2008;10:149–156.
   PubMed Web of Science ®Google Scholar
• Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. The Lancet. 2013;382:260–272.
   PubMed Web of Science ®Google Scholar
• Lawes CM, Rodgers A, Bennett DA, et al. Asia pacific cohort studies collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003;21:707–716.
   PubMed Web of Science ®Google Scholar
• James PA, Oparil S, Carter BL, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;2014(311):507–520.
   Web of Science ®Google Scholar
• Wright JT, Fine LJ, Lackland DT, et al. Evidence supporting a systolic blood pressure goal of less than 150 mmhg in patients aged 60 years or older: the minority view. Ann Internal Med. 2014;160:499–503.
   PubMed Web of Science ®Google Scholar
• Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13-e115.
   Google Scholar
• Lewington S, Clarke R, Qizilbash N, et al. Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913.
   PubMed Web of Science ®Google Scholar
• SPRINT Research Group, Wright JT, Williamson JD, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–2116.
   PubMed Web of Science ®Google Scholar
• Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957–967.
   PubMed Web of Science ®Google Scholar
• Bundy JD, Li C, Stuchlik P, et al. Systolic blood pressure reduction and risk of cardiovascular disease and mortality. JAMA Cardiol. 2017;2:775–781.
   PubMed Web of Science ®Google Scholar
• Cushman WC, Evans GW, ACCORD Study Group, et al.. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575–1585.
   PubMed Web of Science ®Google Scholar
• Reboldi G, Gentile G, Angeli F, et al. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients. J Hypertens. 2011;29:1253–1269.
   PubMed Web of Science ®Google Scholar
• Xie X, Atkins E, Lv J, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2016;387:435–443.
   PubMed Web of Science ®Google Scholar
• Benavente OR, Coffey CS, SPS3 Study Group, et al.. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet. 2013;382:507–515.
   PubMed Web of Science ®Google Scholar
• Wang WT, You LK, Chiang CE, et al. Comparative effectiveness of blood pressure-lowering drugs in patients who have already suffered from stroke: traditional and Bayesian network meta-analysis of randomized trials. Medicine (Baltimore). 2016;95:e3302.
   PubMed Web of Science ®Google Scholar
• Katsanos AH, Filippatou A, Manios E, et al. Blood pressure reduction and secondary stroke prevention: a systematic review and metaregression analysis of randomized clinical trials. Hypertension. 2017;69:171–179.
   PubMed Web of Science ®Google Scholar
• Beckett NS, Peters R, Fletcher AE, et al. HYVET study group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–1898.
   PubMed Web of Science ®Google Scholar
• JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008;31:2115–2127.
   PubMed Web of Science ®Google Scholar
• Ogihara T, Saruta T, Rakugi H, et al. Valsartan in elderly isolated systolic hypertension study group. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension. 2010;56:196–202.
   PubMed Web of Science ®Google Scholar
• Williamson JD, Supiano MA, Applegate WB, et al. SPRINT research group. Intensive vs. standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA. 2016;315:2673–2682.
   PubMed Web of Science ®Google Scholar
• Bavishi C, Bangalore S, Messerli FH. Outcomes of intensive blood pressure lowering in older hypertensive patients. J Am Coll Cardiol. 2017;69:486–493.
   PubMed Web of Science ®Google Scholar
• Williamson JD Intensive blood pressure control reduces risk of mild cognitive impairment and the combined risk of mild cognitive impairment and dementia from the SPRINT MIND study (In Press). [cited 2018 Sept 19]. Avialble from: https://www.alz.org/aaic/re;arases_2018/AAIC18-Wed-developing-topics.asp
   Google Scholar
• Rapsomaniki E, Timmis A, George J, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet. 2014;383:1899–1911.
   PubMed Web of Science ®Google Scholar
• Whelton PK. The elusiveness of population-Wide high blood pressure control. Annu Rev Public Health. 2015;36:109–130.
   PubMed Web of Science ®Google Scholar
• Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777–1783.
   PubMed Web of Science ®Google Scholar
• Banegas JR, Ruilope LM, de la Sierra A, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Engl J Med. 2018;378:1509–1520.
   PubMed Web of Science ®Google Scholar
• Kario K, Saito I, Kushiro T, et al. Morning home blood pressure is a strong predictor of coronary artery disease the HONEST study. J Am Coll Cardiol. 2016;67:1519–1527.
   PubMed Web of Science ®Google Scholar
• Shimada K, Kario K, Kushiro T, et al. Prognostic significance of on-treatment home and clinic blood pressure for predicting cardiovascular events in hypertensive patients in the HONEST study. J Hypertens. 2016;34:1520–1527.
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from Ohasama study. J Am Coll Cardiol. 2005;46:508–515.
   PubMed Web of Science ®Google Scholar
• Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25:2193–2198.
   PubMed Web of Science ®Google Scholar
• Franklin SS, Thijs L, Asayama K, et al. IDACO investigators. The cardiovascular risk of white-coat hypertension. J Am Coll Cardiol. 2016;68:2033–2043.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Reboldi GP, Angeli F, et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension. 2005;45:203–208.
   PubMed Web of Science ®Google Scholar
• Hoshide S, Yano Y, Haimoto H, et al. J-HOP study group. Morning and evening home blood pressure and risks of incident stroke and coronary artery disease in the Japanese general practice population: the Japan morning surge-home blood pressure study. Hypertension. 2016;68:54–61.
   PubMed Web of Science ®Google Scholar
• Kario K, Wang JG. Could 130/80 mmHg be adopted as the diagnostic threshold and management goal of hypertension in consideration of the characteristics of Asian populations? Hypertension. 2018;71:979–984.
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Howard SC, Spence JD. Carotid endarterectomy trialists’ collaboration. Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke. 2003;34:2583–2590.
   PubMed Web of Science ®Google Scholar
• Messerli FH, Mancia G, Conti CR, et al. Dogma disrupted: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006;144:884–893.
   PubMed Web of Science ®Google Scholar
• McEvoy JW, Chen Y, Rawlings A, et al. Diastolic blood pressure, subclinical myocardial damage, and cardiac events: implications for blood pressure control. J Am Coll Cardiol. 2016;68:1713–1722.
   PubMed Web of Science ®Google Scholar
• Ooi WL, Barrett S, Hossain M, et al. Patterns of orthostatic blood pressure change and their clinical correlates in a frail, elderly population. JAMA. 1997;277:1299–1304.
   PubMed Web of Science ®Google Scholar
• Haentjens P, Magaziner J, Colon-Emeric CS, et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med. 2010;152:380–390.
   PubMed Web of Science ®Google Scholar
• Butt DA, Mamdani M, Austin PC, et al. The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch Intern Med. 2012;172:1739–1744.
   PubMedGoogle Scholar
• Asayama K, Ohkubo T, Metoki H, et al. Hypertension objective treatment based on measurement by electrical devices of blood pressure (HOMED-BP). Hypertens Res. 2012;35:1102–1110.
   PubMed Web of Science ®Google Scholar
• Myers MG, Valdivieso M, Kiss A. Use of automated blood pressure measurement to reduce the white coat response. J Hypertens. 2009;27:280–286.
   PubMed Web of Science ®Google Scholar
• Martiniuk AL, Lee CM, Lawes CM, et al. Asia-Pacific cohort studies collaboration. J Hypertens. 2007;25:73–79.
   PubMed Web of Science ®Google Scholar
• Perkovic V, Huxley R, Wu Y, et al. The burden of blood pressure-related disease: a neglected priority for global health. Hypertension. 2007;50:991–997.
   PubMed Web of Science ®Google Scholar
• Hoshide S, Kario K, Yano Y, et al. Association of morning and evening blood pressure at home with asymptomatic organ damage in the J-HOP study. Am J Hypertens. 2014;27:939–947.
   PubMed Web of Science ®Google Scholar
• Kario K. Essential manual of 24-hour blood pressure management from morning to nocturnal hypertension. London: Wiley-Blackwell; 2015.
   Google Scholar
• Kario K, Tomitani N, Matsumoto Y, et al. Research and development of information and communication technology-based home blood pressure monitoring from morning to nocturnal hypertension. Ann Glob Health. 2016;82:254–273.
   PubMed Web of Science ®Google Scholar